Federal Circuit Summaries -
Before Lourie, Reyna, and Chen. Appeal from the Patent Trial and Appeal Board (“PTAB”).
Summary: Nothing in § 41.41(b)(2) bars a reply brief from addressing new arguments raised in the...more
Federal Circuit Summaries -
Before Dyk, Wallach, and Hughes. Appeal from the United States District Court for the District of Delaware.
Summary: A distribution agreement qualifies as an invalidating “offer for sale”...more
2/7/2018
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Generic Drugs ,
Hospira ,
Offers ,
On-Sale Bar ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal ,
Sales & Distribution Agreements